IARTIntegra LifeSciences Holdings Corporation

$749M

FY 2012 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$831M+6.5% YoY

Gross Profit

$516M62.2% margin

Operating Income

$74M8.9% margin

Net Income

$41M5.0% margin

EPS (Diluted)

$0.72

Cash Flow

Operating Cash Flow

$59M

Free Cash Flow

-$10M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$646M

Stockholders' Equity

$518M

Cash & Equivalents

$97M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$831M	$780M	+6.5%
Gross Profit	$516M	$481M	+7.4%
Operating Income	$74M	$55M	+34.4%
Net Income	$41M	$28M	+47.2%

IART FY 2012 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena